Sowell Financial Services’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-961
Closed -$166K 1993
2021
Q1
$166K Sell
961
-251
-21% -$50K 0.01% 1149
2020
Q4
$135K Buy
1,212
+997
+464% +$106K 0.01% 1029
2020
Q3
$23K Sell
215
-2
-0.9% -$244 ﹤0.01% 1505
2020
Q2
$18K Buy
217
+117
+117% +$4.47K ﹤0.01% 1501
2020
Q1
$1K Buy
+100
New +$846 ﹤0.01% 2294

Other funds holding NVAX

Sowell Financial Services's NVAX Position: Q2 2021 in Review

Sowell Financial Services sold out of Novavax (NVAX) in Q2 2021, closing a stake of 961 shares — an estimated $166K sold.

Sowell Financial Services first reported a position in NVAX in Q1 2020 and held it in 5 quarters. The position peaked at $166K in Q1 2021. 408 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

  • Sowell Financial Services reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 961 Novavax shares in Q2 2021, an estimated $166K.
  • Sowell Financial Services first reported a position in Novavax in Q1 2020 and held it in 5 quarters.
  • Sowell Financial Services's Novavax position peaked at $166K in Q1 2021.
  • 408 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.